A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients.
Jordi RelloClaus-Georg KrennGottfried LockerErnst PilgerChristian MadlLaura BalicaThierry DugernierPierre-Francois LaterreHerbert SpapenPieter DepuydtJean-Louis VincentLajos BogárZsuzsanna SzabóBarbara VölgyesRafael MáñezNahit CakarAtilla RamazanogluArzu TopeliMaria A MastruzzoAbel JasovichChristian G RemolifLiliana Del Carmen SoriaMax A Andresen HernandezCarolina Ruiz BalartIldikó KrémerZsolt MolnárFrank von SonnenburgArthur LyonsMichael JoannidisHeinz BurgmannTobias WelteAnton KlinglerRomana HochreiterKerstin WestritschnigPublished in: Critical care (London, England) (2017)
ClinicalTrials.gov, NCT00876252 . Registered on 3 April 2009.
Keyphrases
- phase ii study
- placebo controlled
- intensive care unit
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- open label
- double blind
- locally advanced
- prognostic factors
- randomized controlled trial
- squamous cell carcinoma
- mechanical ventilation
- radiation therapy
- staphylococcus aureus
- patient reported outcomes
- study protocol
- pseudomonas aeruginosa
- rectal cancer